Should I buy or sell Blue Water Biotech stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Blue Water Biotech in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BWV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BWV, but not buy additional shares or sell existing shares. View BWV analyst ratings or view top-rated stocks .

How have BWV shares performed in 2023?

Blue Water Biotech's stock was trading at $0.90 on January 1st, 2023. Since then, BWV shares have decreased by 75.2% and is now trading at $0.2231. View the best growth stocks for 2023 here .

Are investors shorting Blue Water Biotech?

Blue Water Biotech saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 83,400 shares, an increase of 38.3% from the October 31st total of 60,300 shares. Based on an average daily trading volume, of 97,100 shares, the short-interest ratio is currently 0.9 days. Approximately 0.6% of the shares of the stock are short sold. View Blue Water Biotech's Short Interest .

When is Blue Water Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024. View our BWV earnings forecast .

How were Blue Water Biotech's earnings last quarter?

Blue Water Biotech, Inc. (NASDAQ:BWV) posted its quarterly earnings results on Friday, October, 20th. The company reported ($0.43) earnings per share for the quarter.

When did Blue Water Biotech IPO?

(BWV) raised $20 million in an initial public offering (IPO) on Friday, February 18th 2022. The company issued 2,222,222 shares at $9.00 per share.

Who are Blue Water Biotech's major shareholders?

Blue Water Biotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Armistice Capital LLC (6.27%).

How do I buy shares of Blue Water Biotech?

Shares of BWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Blue Water Biotech Stock Price, News & Analysis (NASDAQ:BWV)

$0.22

-0.01 (-4.29%)

(As of 11/29/2023 ET)

Compare

Today's Range: $0.22
▼
$0.25
50-Day Range: $0.22
▼
$0.58
52-Week Range: $0.21
▼
$1.95

Volume: 231,440 shs
Average Volume: 803,495 shs
Market Capitalization: $4.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Blue Water Biotech Stock (NASDAQ:BWV)

Blue Water Biotech, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns ENTADFI, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Vaccines, Inc. and changed its name to Blue Water Biotech, Inc. in April 2023. Blue Water Biotech, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.

BWV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BWV Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BWV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blue Water Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/20/2023
Today: 11/30/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/14/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:BWV
CUSIP: N/A
CIK: 1782107
Web: www.bwbioinc.com
Phone: 513-620-4101
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($1.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-13,420,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -108.19%
Return on Assets: -66.47%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.54
Quick Ratio: 0.46

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.55 per share
Price / Book: 0.41

Miscellaneous

Outstanding Shares: 18,660,000
Free Float: 15,017,000
Market Cap: $4.16 million
Optionable: Not Optionable
Beta: 4.42

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. James R. Sapirstein M.B.A. (Age 62)
R.Ph., Interim Executive Chairman
Comp: $65.62k
Ms. Erin Henderson (Age 48)
Chief Business Officer & Corporate Secretary
Comp: $526.9k
Dr. Neil J. Campbell MA (Age 63)
MBA, President, CEO & Director
Mr. Bruce Harmon (Age 65)
Chief Financial Officer
Dr. Brian Price Ph.D.
Head of Technology Strategy
Mr. Frank A. Jaeger M.A. (Age 52)
M.B.A., Senior VP of Marketing & Business Development
Mr. Andrew D. Skibo Ph.D.
Global Head of Biologics Operations
Mr. Theodore Scott Yoho
Head of Business Development
Dr. Ali I. Fattom Ph.D.
Head of Science & Discovery
Dr. Jay Newmark M.B.A.
M.D., Chief Medical Officer

Key Competitors

View All Competitors

Institutional Ownership

Armistice Capital LLC
Bought 1,128,786 shares on 11/15/2023
Ownership: 6.275%

View All Institutional Transactions

BWV Stock Analysis - Frequently Asked Questions

Should I buy or sell Blue Water Biotech stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Blue Water Biotech in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BWV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BWV, but not buy additional shares or sell existing shares.
View BWV analyst ratings or view top-rated stocks.
How have BWV shares performed in 2023?: Blue Water Biotech's stock was trading at $0.90 on January 1st, 2023. Since then, BWV shares have decreased by 75.2% and is now trading at $0.2231.
View the best growth stocks for 2023 here.
Are investors shorting Blue Water Biotech?: Blue Water Biotech saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 83,400 shares, an increase of 38.3% from the October 31st total of 60,300 shares. Based on an average daily trading volume, of 97,100 shares, the short-interest ratio is currently 0.9 days. Approximately 0.6% of the shares of the stock are short sold.
View Blue Water Biotech's Short Interest.
When is Blue Water Biotech's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024.
View our BWV earnings forecast.

How were Blue Water Biotech's earnings last quarter?: Blue Water Biotech, Inc. (NASDAQ:BWV) posted its quarterly earnings results on Friday, October, 20th. The company reported ($0.43) earnings per share for the quarter.
When did Blue Water Biotech IPO?: (BWV) raised $20 million in an initial public offering (IPO) on Friday, February 18th 2022. The company issued 2,222,222 shares at $9.00 per share.
Who are Blue Water Biotech's major shareholders?: Blue Water Biotech's stock is owned by a number of institutional and retail investors. Top institutional investors include Armistice Capital LLC (6.27%).
How do I buy shares of Blue Water Biotech?: Shares of BWV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BWV) was last updated on 11/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial